{"id":35739,"date":"2025-05-30T15:53:11","date_gmt":"2025-05-30T12:53:11","guid":{"rendered":"https:\/\/massivebio.com\/?p=35739"},"modified":"2025-07-09T15:47:35","modified_gmt":"2025-07-09T12:47:35","slug":"massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25","status":"publish","type":"post","link":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/","title":{"rendered":"Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Chicago, IL \u2013 May 30, 2025 &#8211;<\/strong> Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30 to June 3 at McCormick Place in Chicago, Illinois. The company is exhibiting at <strong>Booth IH04 in the Innovation Hub<\/strong>, where its team is presenting its technology platform and initiatives to support clinical trial enrollment and data-driven decision-making in oncology.<\/p>\n<p>Massive Bio\u2019s participation reflects its commitment to expanding access to clinical research through digital innovation and real-world data.<\/p>\n<p><strong>&#8220;At Massive Bio, we\u2019ve always believed that access to clinical trials should not depend on geography, income, or system navigation,&#8221;<\/strong> said <strong>Selin Kurnaz<\/strong>, Co-founder and Chief Executive Officer of Massive Bio. <strong>&#8220;ASCO25 is more than a conference. It\u2019s where meaningful partnerships are formed and shared challenges are addressed. We\u2019re honored to stand among those pushing the boundaries of what\u2019s possible for cancer patients worldwide.&#8221;<\/strong><\/p>\n<p>Selin Kurnaz will be participating in the PCC Drop-In Session at ASCO on May 30, 2025. This event brings together key stakeholders in precision oncology to discuss advancements in comprehensive genomic profiling, clinical trial matching, and patient-centered care.<\/p>\n<p><strong>&#8220;ASCO is where science, technology, and care delivery converge,&#8221;<\/strong> said <strong>\u00c7a\u011fatay \u00c7ulcuo\u011flu<\/strong>, Co-founder, Chief Technology Officer and Chief Operating Officer of Massive Bio. <strong>&#8220;We\u2019re bringing not just advanced technology, but a vision for a more connected and intelligent ecosystem. One where data informs better decisions and every patient has a fair chance to engage in research.&#8221;<\/strong><\/p>\n<h2><strong>Scientific Contributions by Dr. Arturo Loaiza-Bonilla<\/strong><\/h2>\n<p>Massive Bio\u2019s Co-founder and Chief Medical Officer, <strong>Dr. Arturo Loaiza-Bonilla<\/strong>, is delivering two presentations at ASCO25:<\/p>\n<ul>\n<li><strong>Poster Presentation<\/strong><br \/>\n<strong>Title<\/strong>: <em>Transforming oncology clinical trial matching through multi-agent AI and an oncology-specific knowledge graph: A prospective evaluation in 3,800 patients<\/em><br \/>\n<strong>Track<\/strong>: Care Delivery \/ Models of Care<br \/>\n<strong>Abstract<\/strong>: 1554 | <strong>Poster Board<\/strong>: 320<\/li>\n<\/ul>\n<ul>\n<li><strong>Oral Presentation (ASCO\/ESMO Joint Session)<\/strong><br \/>\n<strong>Title<\/strong>: <em>Advancing Cancer Research and Patient-Centric Pre-Screening Hubs\u2014Leveraging Digital Technologies<\/em><br \/>\n<strong>Date and Time<\/strong>: June 1, 2025, 1:31 to 1:43 PM CDT<\/li>\n<\/ul>\n<p>Dr. Loaiza-Bonilla is also co-author of a recent <em>NEJM AI<\/em> article titled <em>\u201cHarnessing Moravec\u2019s Paradox in Health Care: A New Era of Collaborative Intelligence,\u201d<\/em> which explores the role of AI in improving research workflows and enabling patient-centric trial access.<\/p>\n<p><strong>&#8220;Technology has matured to a point where it can meet patients at the right time, with the right opportunity, no matter how complex the diagnosis,&#8221;<\/strong> said <strong>Dr. Arturo Loaiza-Bonilla<\/strong>, Co-founder and Chief Medical Officer. <strong>&#8220;At ASCO25, we\u2019re proud to share how real-world data, artificial intelligence, and clinical expertise are coming together to break longstanding barriers in oncology research.&#8221;<\/strong><\/p>\n<h2><strong>Highlights at Booth IH04<\/strong><\/h2>\n<p>ASCO25 attendees visiting Massive Bio\u2019s booth can:<\/p>\n<ul>\n<li>View demonstrations of the company\u2019s AI-driven clinical trial matching platform<\/li>\n<\/ul>\n<ul>\n<li>Learn more about <strong>DUO<\/strong>, a real-world data solution for healthcare analytics and provider engagement<\/li>\n<\/ul>\n<ul>\n<li>Meet with the clinical and commercial teams to explore collaboration opportunities<\/li>\n<\/ul>\n<p>Meetings can be scheduled in advance at <a href=\"https:\/\/www.massivebio.com\/asco25\/\"><strong>www.massivebio.com\/asco25\/<\/strong><\/a><\/p>\n<h3><strong>About Massive Bio <\/strong><\/h3>\n<p>Massive Bio, co-founded by <a href=\"https:\/\/www.linkedin.com\/in\/selinkurnaz\/\" target=\"_blank\" rel=\"noopener\">Selin Kurnaz<\/a>, <a href=\"https:\/\/www.linkedin.com\/in\/arturoloaizabonilla\/\" target=\"_blank\" rel=\"noopener\">Arturo Loaiza-Bonilla<\/a>, and <a href=\"https:\/\/www.linkedin.com\/in\/cagatayculcuoglu\/\" target=\"_blank\" rel=\"noopener\">\u00c7a\u011fatay \u00c7ulcuo\u011flu<\/a>, transforms the pharmaceutical value chain with AI-driven solutions. As an AI-enabled real-world data company, it streamlines the patient journey, enhances access to advanced treatment options, and optimizes clinical trials. Massive Bio collaborates with pharmaceutical companies, research organizations, and healthcare institutions worldwide. A founding member of the CancerX public-private partnership and participant in the Cancer Moonshot White House initiative, the company has received recognition from the National Cancer Institute and operates across 17 countries with a global team of over 100 employees. For more information, visit <a href=\"https:\/\/massivebio.com\/\">www.massivebio.com<\/a>.<\/p>\n<h3><strong>Contacts<\/strong><\/h3>\n<p><strong>Massive Bio<br \/>\n<\/strong><strong>Mert Turkkan<br \/>\n<\/strong>Marketing Director<br \/>\n<a href=\"tel:+16464614946\">+1 646 461 4946<\/a><br \/>\n<a href=\"mailto:pr@massivebio.com\">pr@massivebio.com<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Chicago, IL \u2013 May 30, 2025 &#8211; Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30 to June 3 at McCormick Place in Chicago, Illinois. The company is exhibiting at Booth IH04...","protected":false},"author":11,"featured_media":35740,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-35739","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25<\/title>\n<meta name=\"description\" content=\"Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25 %\" \/>\n<meta property=\"og:description\" content=\"Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-30T12:53:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-09T12:47:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/05\/asco-website-pr-visual-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2432\" \/>\n\t<meta property=\"og:image:height\" content=\"1822\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25","description":"Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/","og_locale":"en_US","og_type":"article","og_title":"Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25 %","og_description":"Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.","og_url":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-05-30T12:53:11+00:00","article_modified_time":"2025-07-09T12:47:35+00:00","og_image":[{"width":2432,"height":1822,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/05\/asco-website-pr-visual-1.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25","datePublished":"2025-05-30T12:53:11+00:00","dateModified":"2025-07-09T12:47:35+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/"},"wordCount":667,"commentCount":0,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/05\/asco-website-pr-visual-1.webp","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/","url":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/","name":"Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/05\/asco-website-pr-visual-1.webp","datePublished":"2025-05-30T12:53:11+00:00","dateModified":"2025-07-09T12:47:35+00:00","description":"Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.","breadcrumb":{"@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/05\/asco-website-pr-visual-1.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/05\/asco-website-pr-visual-1.webp","width":2432,"height":1822,"caption":"asco website pr visual 1"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/massive-bio-to-showcase-ai-driven-oncology-innovations-at-asco25\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/35739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=35739"}],"version-history":[{"count":13,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/35739\/revisions"}],"predecessor-version":[{"id":36172,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/35739\/revisions\/36172"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/35740"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=35739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=35739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=35739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}